Impact of Discontinuing Fluoroquinolone Prophylaxis on Early Mortality After Allogeneic Marrow or Peripheral Blood SCT With Myeloablative Conditioning

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Late Mortality After Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism - A Report From the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Failure of Sustained Engraftment After Non-Myeloablative Conditioning With Low-Dose TBI and T Cell-Reduced Allogeneic Peripheral Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2001English

Impact of Lymphocyte and Monocyte Recovery on the Outcomes of Allogeneic Hematopoietic SCT With Fludarabine and Melphalan Conditioning

Bone Marrow Transplantation
TransplantationHematology
2012English

Similar Invasive Fungal Infection Rates and Survival After Allogeneic Hematopoietic Cell Transplantation With Umbilical Cord Blood and Bone Marrow or Peripheral Blood Graft Sources

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Early Allogeneic Blood Stem Cell Transplantation After Modified Conditioning Therapy During Marrow Aplasia: Stable Remission in High-Risk Acute Myeloid Leukemia

Bone Marrow Transplantation
TransplantationHematology
2001English

Incidence and Mortality of Adenovirus Infection After Pediatric Allogeneic SCT – A Comparison Between Bone Marrow and CD3/19 Depleted PBSC

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Decreased Insulin Secretion in Patients Receiving Tacrolimus as GVHD Prophylaxis After Allogeneic Hematopoietic SCT

Bone Marrow Transplantation
TransplantationHematology
2009English

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy